Concomitance of IgA Nephropathy and Diabetic Nephropathy in a Kidney Allograft: Case Report and Review of the Literature

被引：3

作者：

Kamal, L. ^{[1
]}

Salvatore, S. ^{[1
]}

Hartono, C. ^{[1
,2
]}

Perlman, A. ^{[1
,2
]}

机构：

[1] New York Presbyterian Hosp, Cornell Med Coll, New York, NY 10021 USA

[2] Rogosin Inst, New York, NY USA

来源：

TRANSPLANTATION PROCEEDINGS | 2014年 / 46卷 / 07期

关键词：

MYCOPHENOLATE-MOFETIL; RENAL-ALLOGRAFTS; LONG-TERM; CONTROLLED-TRIAL; DOUBLE-BLIND; TRANSPLANTATION; RECURRENT; GLOMERULONEPHRITIS; PLACEBO; DONORS;

D O I：

10.1016/j.transproceed.2014.06.048

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Whereas diabetic nephropathy is the most common cause of end-stage renal disease (ESRD), IgA nephropathy is the most common glomerulonephritis in the world. We report a case of a kidney transplant recipient whose native renal disease was presumptive diabetic nephropathy. Five years after transplantation, the patient developed proteinuria, hematuria, and allograft dysfunction. Transplant biopsy revealed IgA nephropathy super-imposed on diabetic nephropathy.

引用

页码：2396 / 2399

页数：4

共 17 条

[1] Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome [J].

D'Amico, G .

SEMINARS IN NEPHROLOGY, 2004, 24 (03) :179-196

[2] Recurrent IgA nephropathy after renal transplantation [J].

Floege, J .

SEMINARS IN NEPHROLOGY, 2004, 24 (03) :287-291

[3] Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy:: a double-blind randomized controlled trial [J].

Frisch, G ;

Lin, J ;

Rosenstock, J ;

Markowitz, G ;

D'Agati, V ;

Radhakrishnan, J ;

Preddie, D ;

Crew, J ;

Valeri, A ;

Appel, G .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (10) :2139-2145

[4] Recurrent and de novo renal diseases after renal transplantation: A report from the renal allograft disease registry [J].

Hariharan, S ;

Peddi, VR ;

Savin, VJ ;

Johnson, CP ;

First, MR ;

Roza, AM ;

Adams, MB .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (06) :928-931

[5] A primer on recurrent and de novo glomerulonephritis in renal allografts [J].

Ivanyi, Bela .

NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (08) :446-457

[6] IgA nephropathy in renal allografts-recurrence and graft dysfunction [J].

Jeong, HJ ;

Huh, KH ;

Kim, YS ;

Kim, SI .

YONSEI MEDICAL JOURNAL, 2004, 45 (06) :1043-1048

[7] Donor-transmitted IgA nephropathy: Long-term follow-up of kidney donors and recipients [J].

Koselj, M ;

Rott, T ;

Kandus, A ;

Vizjak, A ;

Malovrh, M .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (08) :3406-3407

[8] Hong Kong study using valsartan in IgA nephropathy (HKVIN): A double-blind, randomized, placebo-controlled study [J].

Li, Philip Kam-Tao ;

Leung, Chi Bon ;

Chow, Kai Ming ;

Cheng, Yuk Lun ;

Fung, Samuel Ka-Shun ;

Mak, Siu Ka ;

Tang, Anthony Wing-Chung ;

Wong, Teresa Yuk-Hwa ;

Yung, Chun Yu ;

Yung, Jonathan Chee-Unn ;

Yu, Alex Wai-Yin ;

Szeto, Cheuk Chun .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (05) :751-760

[9] Mycophenolate mofetil for systemic vasculitis and IgA nephropathy [J].

Nowack, R ;

Birck, R ;

vanderWoude, FJ .

LANCET, 1997, 349 (9054) :774-774

[10] Kidney transplantation in patients with IgA mesangial glomerulonephritis [J].

Ponticelli, C ;

Traversi, L ;

Feliciani, A ;

Cesana, BM ;

Banfi, G ;

Tarantino, A .

KIDNEY INTERNATIONAL, 2001, 60 (05) :1948-1954

← 1 2 →